|
|
|
| At AustinPx, we transform complex drug delivery challenges into tailored solutions. As a former pharma sponsor, we bring bedside, boardroom, and courtroom perspective to every formulation. Our scientists collaborate across disciplines to translate data into action—offering scalable, bioavailable, and patient-centric solutions. With a proven, data-driven toolkit, we support your molecule’s success from early development through manufacturing, addressing the needs of patients, investors, and regulators alike. |
|
|
|
|
|
|
|
|
By Louis Garguilo, chief editor, Outsourced Pharma | It’s rare when a CDMO’s market restructuring leads to thoughts about national health policy. But as Chief Editor Louis Garguilo wrote his recent editorial on Lonza’s decision to focus on biologics, it brought to mind a government policy that may have contributed to the company’s restructuring. No, it's not tariffs. | |
|
|
|
INDUSTRY INSIGHTS CONTINUED |
|
|
|
|
|
|
|
|
|
Two-Side Labeler For Drug Packaging | HERMA | The 362 Master series two-side labeler offers a wide range of equipment options with various print and label presence checks in combination with bad label return and product rejection. |
|
|
Capacity Update April 2025: Small Molecule | SK pharmteco | Join Nicholas Duda, Executive Director of Business Development, as he highlights our available capacity across North America, Europe, and Asia, and our unique capabilities. |
|
|
OUTSOURCED PHARMA CAPACITY UPDATE |
|
|
|
CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capacities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs. |
|
|
| Connect With Outsourced Pharma: |
|
|
|
